<DOC>
	<DOCNO>NCT00209677</DOCNO>
	<brief_summary>To assess usefulness Gemcitabine plus S-1 therapy base antitumor effect survival period . By perform phase I/II study combination patient inoperable postoperative pancreatic cancer .</brief_summary>
	<brief_title>Phase I/II Study Oral S-1 Plus Gemcitabine Patients With Metastatic Pancreatic Cancer</brief_title>
	<detailed_description>A multicenter Open-label , single-arm , phase I/II clinical trial conduct patient histological stage IV Pancreatic cancer give gemcitabine plus S-1 . The usefulness regimens 1st line therapy pancreatic cancer evaluate disease-free survival ( DFS ) , median survival time ( MST ) , incidence severity adverse event .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<criteria>1 . Histological diagnosis pancreatic adenocarcinoma . 2 . Measurable assessable lesion ( Except Phase I ) . 3 . Age : 20 ~ 75 year . 4 . Karnofsky Performance Status ( KPS ) &gt; 70 . 5 . No prior chemotherapy 6 . No history treatment gemcitabine S1 . 7 . No history radiotherapy abdomen . 8 . Oral intake S1 possible . 9 . Adequate function major organ ( bone marrow , heart , lung , liver etc. ) . WBC 3,500/mm3 Neutrophil 2,000/mm3 . Hb 9.0 g/dl . Platelet count 100,000/mm3 . GOT GPT 2.5 time upper limit normal ( exclude liver metastasis ) . TBil 2.0 mg/dl . Creatinine within upper limit normal ) . Normal ECG ( consider clinically unimportant arrhythmias ischemic change ) . 10 . Predicted survival &gt; 3 month . 11 . Able give write informed consent . 1 . Severe pleural effusion ascites . 2 . Metastasis central nervous system ( CNS ) . 3 . Active gastrointestinal bleeding . 4 . Active infection . 5 . Liver cirrhosis 6 . Uncontrolled ischemic heart disease . 7 . Serious complication ( intestinal paralysis , intestinal obstruction , interstitial pneumonia pulmonary fibrosis , uncontrolled diabetes mellitus , heart failure , renal failure , hepatic failure ) . 8 . Active multiple cancer . 9 . Severe mental disorder . 10 . Pregnancy , possible pregnancy , breastfeed . 11 . Flucytosine treatment 12 . Judged ineligible protocol attend physician .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2007</verification_date>
</DOC>